V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia

Medicines by ATC code V03AE Drugs for treatment of hyperkalemia and hyperphosphatemia

• Veltassa Patient leaflet Summary of medicine characteristics
• Lokelma Patient leaflet Summary of medicine characteristics
• Renagel Patient leaflet Summary of medicine characteristics
• Renvela Patient leaflet Summary of medicine characteristics
• Sevelamer carbonate Winthrop (previously Sevelamer carbonate Zentiva) Patient leaflet Summary of medicine characteristics
• Velphoro Patient leaflet Summary of medicine characteristics
• Fexeric Patient leaflet Summary of medicine characteristics
• Tasermity Patient leaflet Summary of medicine characteristics
• BindRen Patient leaflet Summary of medicine characteristics

Other names of the ATC group

• Czech: V03AE Léčiva k terapii hyperkalemie a hyperfosfatemie
• French: V03AE médicaments de l'hyperkaliémie et de l'hyperphosphatémie
• German: V03AE Mittel zur Behandlung der Hyperkaliämie und Hyperphosphatämie
• Spanish: V03AE MEDICAMENTOS TRATAMIENTO DE LA HIPERKALEMIA
• German: V03AE Mittel zur Behandlung der Hyperkaliämie und Hyperphosphatämie
• Italian: V03AE FARMACI PER IL TRATTAMENTO DI IPERKALIEMIA ED IPERFOSFATEMIA
• Polish: V03AE Leki stosowane w leczeniu hiperkaliemii i hiperfosfatemii
• Turkish: V03AE Hiperkalemi ve hiperfosfatemi tedavisi için ilaçlar
• Portuguese (Brazil): V03AE Fármacos para o tratamento da hipercaliémia e hiperfosfatémia